98%
921
2 minutes
20
Cervical cancer, the fourth most prevalent cancer in women, is the most common malignant tumor of the female reproductive system and one of the most frequently diagnosed cancers during pregnancy. In Brazil, cervical cancer screening is conducted via Pap smear examination of the cervix, with a false-negative rate ranging between 2 and 50%. Colposcopy is recommended when the Pap smear results reveal abnormalities suggestive of malignancy, and biopsy is reserved for patients who are pregnant only when invasive lesions are suspected. We report the case of a pregnant woman who developed a tumor in the inguinal region, which was biopsied and diagnosed as squamous cell carcinoma. An investigation was performed to identify the primary focus of the tumor. Since the Pap smear was normal, two other potential primary sites were investigated, including the colorectal and bladder regions, which were normal. Despite normal cervical cytopathological examination results and due to the high suspicion of a primary cervical focus, additional diagnostic evaluations were performed, which confirmed cervical squamous cell carcinoma as the primary site. We described this case due to the lack of similar reports in the literature of cervical cancer diagnosed in pregnant or non-pregnant patients with normal oncotic Pap smears, initially diagnosed by biopsy of an inguinal tumor, and to highlight the importance of complementing the diagnostic process with colposcopy in patients with a high clinical suspicion of cervical cancer, even in cases of negative Pap smear results.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378519 | PMC |
http://dx.doi.org/10.3389/fmed.2025.1648261 | DOI Listing |
Health Expect
October 2025
Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Introduction: Despite high coverage of routine childhood vaccines, uptake of the human papillomavirus (HPV) vaccine in the Pacific Island nation of Tonga has been slow. Culturally appropriate communication resources on the importance, safety, and effectiveness of the HPV vaccine are critical to support acceptance and uptake. To develop these resources, it is important to understand what people want to know.
View Article and Find Full Text PDFJ Relig Health
September 2025
Department of Midwifery, Faculty of Health Sciences, Agri Ibrahim Cecen University, Agri, Turkey.
This study aims to examine the effect of education interventions given to women with religious orientation on cervical cancer and Pap smear test health beliefs.The study used a quasi-experimental research design with the pre-test-post-test control group. It was conducted in Qur'an courses in a province in eastern Turkey between January and October 2023.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
September 2025
Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address:
Purpose: Recent immunotherapy trials in locally advanced cervical cancer report high PD-L1 positivity rates whereas academic multicentric initiatives report a lower PD-L1 positivity. These observations necessitate cross-clone comparison to understand the observed differences.
Methods: Two different clones used in previous multicentric international studies SP142 (BIOEMBRACE) and 22C3 (KEYNOTE-A18) were used to test PD-L1 positivity in a pilot cohort of FIGO 2018 stage III cervical cancer patients recruited in a phase III trial.
Biosens Bioelectron
September 2025
Materials Artificial Intelligence Center, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. Electronic address:
Screening for high-risk human papillomavirus (hrHPV) infection is essential for cervical cancer prevention. However, developing a simple, portable, and low-cost hrHPV genotyping method remains challenging, particularly in resource-limited settings. Herein, we present an innovative amplification-free, point-of-care hrHPV genotyping platform integrating CRISPR/Cas12a with alkaline phosphatase (ALP)-mediated surface plasmon effect.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
September 2025
Aberdeen Centre for Women's Health Research (ACWHR), Institute Applied Health Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, United Kingdom. Electronic address:
Background: Human papillomavirus (HPV) vaccination has reduced rates of cervical cancer. Research suggests that women with HPV, precancerous disease, and prior invasive treatments are at increased risk of preterm birth. This study aimed to determine if there is a reduction in adverse obstetric outcomes for HPV vaccinated women.
View Article and Find Full Text PDF